|
KIF3B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6295853555448E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.60871316268185E-13 |
| Normal-vs-Stage2 |
1.198020E-03 |
| Normal-vs-Stage3 |
2.25808260978511E-12 |
| Normal-vs-Stage4 |
1.84341431008761E-12 |
| Stage1-vs-Stage2 |
8.299800E-03 |
| Stage1-vs-Stage3 |
2.379400E-01 |
| Stage1-vs-Stage4 |
1.191930E-02 |
| Stage2-vs-Stage3 |
2.557200E-03 |
| Stage2-vs-Stage4 |
2.834400E-04 |
| Stage3-vs-Stage4 |
2.478000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
4.11240000000035E-05 |
| Normal-vs-Asian |
1.13010000246661E-08 |
| Caucasian-vs-AfricanAmerican |
3.222400E-01 |
| Caucasian-vs-Asian |
9.775200E-01 |
| AfricanAmerican-vs-Asian |
4.016800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.10382880192628E-15 |
| Normal-vs-Female |
2.35456099062503E-12 |
| Male-vs-Female |
4.714400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.39364125479369E-12 |
| Normal-vs-Age(41-60Yrs) |
1.17128529097954E-13 |
| Normal-vs-Age(61-80Yrs) |
3.25759996755437E-09 |
| Normal-vs-Age(81-100Yrs) |
8.3258000000086E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.584600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.070200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.529200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.061200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.718400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.517600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.791900E-02 |
| Classical-VS-Follicular |
1.315770E-01 |
| Classical-VS-Other |
1.213960E-01 |
| Classical-VS-Normal |
1.63224989080391E-12 |
| Tall-VS-Follicular |
6.781000E-03 |
| Tall-VS-Other |
4.403400E-01 |
| Tall-VS-Normal |
5.54679635555999E-11 |
| Follicular-VS-Other |
1.018570E-01 |
| Follicular-VS-Normal |
1.53449999999999E-05 |
| Other-VS-Normal |
8.03230000000488E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.34510213867634E-11 |
| Normal-vs-N1 |
6.30495655684626E-13 |
| N0-vs-N1 |
3.962600E-03 |
|
|
